Suppr超能文献

下咽癌患者的外科治疗及临床病程

Surgical treatment and clinical course of patients with hypopharyngeal carcinoma.

作者信息

Pesko P, Sabljak P, Bjelovic M, Stojakov D, Simic A, Nenadic B, Bumbasirevic M, Trajkovic G, Djukic V

机构信息

Department of Esophagogastric Surgery, First University Surgical Hospital, Belgrade.

出版信息

Dis Esophagus. 2006;19(4):248-53. doi: 10.1111/j.1442-2050.2006.00585.x.

Abstract

In the period between 1 January 1978 and 1 January 2004, 85 patients with hypopharyngeal squamocellular carcinoma were admitted at the Department of Esophagogastric Surgery in Belgrade. Among them, only 46 patients (54.1%) had radical surgical en-block resection and functional neck dissection, and they were included into an historical cohort study. In 40 patients a pharyngolaryngoesophagectomy was performed using for reconstruction, stomach tissue in 29 and colon tissue in 11 patients. Since 1996, in six patients with localized hypopharyngeal carcinoma pharyngolaryngectomy was performed with resection of cervical esophagus and free jejunal graft interposition. The overall incidence of morbidity was 50.0% and the overall mortality rate was 13.0% (6 patients). Mean hospital stay was 35 days (range, 18-78 days). The median survival of patients was 26 months, and overall 5-year survival rate was 26.5%. At present, surgery seems to be the appropriate therapeutic choice for patients with advanced hypopharyngeal carcinoma, providing a definitive palliation of dysphagia and relatively good long-term survival. At our Institution, after pharyngolaryngoesophagectomy, reconstructive method of choice is gastric 'pull-up', and the colon is used only when stomach tissue is not available, that is, previous gastric resections, inappropriate blood supply, synchronous gastric carcinoma and so on. Recently, pharyngolaryngectomy and free jejunal transfer has become the standard technique in patients with small carcinomas (up to 3 cm) confined to the hypopharynx in the absence of synchronous esophageal and/or gastric carcinoma.

摘要

1978年1月1日至2004年1月1日期间,贝尔格莱德食管胃外科收治了85例下咽鳞状细胞癌患者。其中,仅46例患者(54.1%)接受了根治性手术整块切除及功能性颈清扫术,并被纳入一项历史性队列研究。40例患者接受了下咽食管切除术,其中29例采用胃组织重建,11例采用结肠组织重建。自1996年以来,6例局限性下咽癌患者接受了下咽切除术,同时切除颈段食管并游离空肠移植。总体发病率为50.0%,总体死亡率为13.0%(6例患者)。平均住院时间为35天(范围18 - 78天)。患者的中位生存期为26个月,总体5年生存率为26.5%。目前,手术似乎是晚期下咽癌患者合适的治疗选择,可明确缓解吞咽困难并提供相对较好的长期生存。在我们机构,下咽食管切除术后,首选的重建方法是胃“上提”术,仅在无法获取胃组织时才使用结肠,即既往有胃切除术、血供不佳、同步性胃癌等情况。最近,下咽切除术及游离空肠移植已成为下咽局限性小癌(最大3 cm)且无同步性食管癌和/或胃癌患者的标准技术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验